Programmed cell death (PCD, mainly including apoptosis, necrosis, ferroptosis, pyroptosis,
and autophagy) and immunogenic cell death (ICD), as important cell death mechanisms, are …

Low immunogenicity and immunosuppressive tumor microenvironments are major hurdles
in the application of cancer immunotherapy. To date, several immunogenic cell death (ICD) …

Most cancer-related deaths are due to metastasis or recurrence. Therefore, the ultimate goal
of cancer therapy will be to treat metastatic and recurrent cancers. Combination therapy for …

Combined cancer immunotherapy has demonstrated promising potential with an amplified
antitumor response and immunosuppressive tumor microenvironment (TME) modulation …

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
ineffective treatment and poor prognosis. It is in great demand to develop a novel theranostic …

Nanomedicine is a novel field of study that involves the use of nanomaterials to address
challenges and issues that are associated with conventional therapeutics for cancer …

Nanomedicines hold promise for the treatment of various diseases. However, treating
cancer metastasis remains highly challenging. In this study, we synthesized gold nanorods …

Hydrogels are cross-linked three-dimensional polymer networks that have tissue-like
properties. Dynamic covalent bonds (DCB) can be utilized as hydrogel cross-links to impart …

The emergence of semiconductor polymers (SPs) has paved the way for obtaining smart
and multifunctional semiconductor polymer nanoparticles (SPNs) with distinctive …

Recent focus on cancer immunotherapies has led to significant interest in the development
of therapeutic strategies that can lead to immunogenic cell death (ICD), which can cause …